aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
5.07
+0.04 (0.80%)
At close: Jun 30, 2025, 4:00 PM
5.10
+0.03 (0.59%)
After-hours: Jun 30, 2025, 7:52 PM EDT
aTyr Pharma Stock Forecast
Stock Price Forecast
The 6 analysts that cover aTyr Pharma stock have a consensus rating of "Strong Buy" and an average price target of $20.2, which forecasts a 298.42% increase in the stock price over the next year. The lowest target is $9 and the highest is $35.
Price Target: $20.2 (+298.42%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for aTyr Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $17 → $25 | Buy | Maintains | $17 → $25 | +393.10% | Jun 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +590.34% | Jun 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +590.34% | May 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +590.34% | Mar 14, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $16 | Buy | Initiates | $16 | +215.58% | Feb 18, 2025 |
Financial Forecast
Revenue This Year
2.49M
from 235.00K
Increased by 960.85%
Revenue Next Year
34.49M
from 2.49M
Increased by 1,283.47%
EPS This Year
-0.67
from -0.86
EPS Next Year
-0.65
from -0.67
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 12.6M | 123.9M | 240.6M |
| Avg | 2.5M | 34.5M | 142.7M |
| Low | n/a | n/a | 45.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 5,261.7% | 4,869.9% | 597.5% |
| Avg | 960.9% | 1,283.5% | 313.6% |
| Low | - | - | 31.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.58 | - | 1.04 |
| Avg | -0.67 | -0.65 | 0.31 |
| Low | -0.77 | -1.26 | -0.31 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.